Home | Kp Advocacy And Policy

At KP Advocacy & Policy we build effective, tailored and more inclusive biopharma advocacy and policy strategies by embedding real patient insights at every stage.

Leaders in Biotech Advocacy & Policy

We help biopharma teams engage patient communities, inform clinical trial design, accelerate recruitment, and strengthen access strategy by embedding patient insights where they matter most: early and often.

Our work drives measurable impact in drug development and commercialization, focused on rare disease and oncology, where every delay or misstep isn’t just costly—it’s consequential. By aligning compliance, commercial strategy, and real-world execution, we turn patient engagement into a strategic advantage.

“By engaging patients in thousands of conversations, Kathy’s team gathers actionable insights that influence scientific, medical, real world evidence, and commercial spheres of the company..."

- Martha Stone

CEO, STERITAS

“Kathy possesses a rare ability to bridge the diverse and often nuanced needs of patients across a wide spectrum of rare diseases, consistently delivering comprehensive, meaningful resources to the broader patient community...”

- Glenda Thomas,

Rare Disease Patient Advocate

"...She brought not only deep expertise in rare disease policy and advocacy but also a thoughtful approach to leadership..."

- Stacey Frisk

Executive Director RDCC